Guy‐André Loeuille

784 total citations
17 papers, 258 citations indexed

About

Guy‐André Loeuille is a scholar working on Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Guy‐André Loeuille has authored 17 papers receiving a total of 258 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 6 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Guy‐André Loeuille's work include Cystic Fibrosis Research Advances (7 papers), Sexual Differentiation and Disorders (2 papers) and Antibiotic Resistance in Bacteria (2 papers). Guy‐André Loeuille is often cited by papers focused on Cystic Fibrosis Research Advances (7 papers), Sexual Differentiation and Disorders (2 papers) and Antibiotic Resistance in Bacteria (2 papers). Guy‐André Loeuille collaborates with scholars based in France and Monaco. Guy‐André Loeuille's co-authors include Dominique Turck, P. Vic, S. Ategbo, A. Deschildre, A Sardet, M.O. Husson, J. P. Farriaux, Frédèric Gottrand, R. Leroy and H. Hanaire and has published in prestigious journals such as Archives of Disease in Childhood, Pediatric Research and Pediatric Pulmonology.

In The Last Decade

Guy‐André Loeuille

16 papers receiving 252 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guy‐André Loeuille France 9 129 66 57 51 48 17 258
Alan B Osher United States 10 322 2.5× 35 0.5× 22 0.4× 17 0.3× 6 0.1× 15 402
S. B. Doldi Italy 12 117 0.9× 35 0.5× 80 1.4× 11 0.2× 110 2.3× 28 862
Hafeez Abiola Afolabi Malaysia 11 23 0.2× 20 0.3× 20 0.4× 7 0.1× 24 0.5× 29 271
Thierry Prigogine Belgium 11 269 2.1× 29 0.4× 13 0.2× 12 0.2× 29 0.6× 21 378
Gregor P.M. Mannes Netherlands 7 219 1.7× 48 0.7× 18 0.3× 24 0.5× 4 0.1× 10 298
Mehran Kouchek Iran 11 31 0.2× 58 0.9× 32 0.6× 39 0.8× 5 0.1× 36 285
Bryan Stierman United States 8 16 0.1× 17 0.3× 19 0.3× 7 0.1× 22 0.5× 13 255
BR Bistrian United States 10 68 0.5× 56 0.8× 11 0.2× 2 0.0× 27 0.6× 12 463
Emmanuelle Jaillette France 14 258 2.0× 133 2.0× 10 0.2× 29 0.6× 3 0.1× 24 459
Zakaria Hamdan Palestinian Territory 10 26 0.2× 33 0.5× 11 0.2× 10 0.2× 41 0.9× 30 244

Countries citing papers authored by Guy‐André Loeuille

Since Specialization
Citations

This map shows the geographic impact of Guy‐André Loeuille's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guy‐André Loeuille with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guy‐André Loeuille more than expected).

Fields of papers citing papers by Guy‐André Loeuille

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guy‐André Loeuille. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guy‐André Loeuille. The network helps show where Guy‐André Loeuille may publish in the future.

Co-authorship network of co-authors of Guy‐André Loeuille

This figure shows the co-authorship network connecting the top 25 collaborators of Guy‐André Loeuille. A scholar is included among the top collaborators of Guy‐André Loeuille based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guy‐André Loeuille. Guy‐André Loeuille is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Lassmann‐Vague, V., S. Clavel, Bruno Guerci, et al.. (2010). When to treat a diabetic patient using an external insulin pump. Expert consensus. Société francophone du diabète (ex ALFEDIAM) 2009. Diabetes & Metabolism. 36(1). 79–85. 39 indexed citations
2.
Vanhelst, Jérémy, Frédéric Marchand, Paul S. Fardy, et al.. (2010). The CEMHaVi Program. Journal of Cardiopulmonary Rehabilitation and Prevention. 30(3). 181–185. 13 indexed citations
3.
Béghin, Laurent, L. Michaud, Guy‐André Loeuille, et al.. (2009). Changes in lung function in young cystic fibrosis patients between two courses of intravenous antibiotics against Pseudomonas aeruginosa. Pediatric Pulmonology. 44(5). 464–471. 5 indexed citations
4.
Clavel, S., Bruno Guerci, H. Hanaire, et al.. (2009). Quand et comment traiter un patient diabétique par pompe à insuline externe ?. Médecine des Maladies Métaboliques. 3(2). 219–227.
5.
Mallet, E., J. Gaudelus, P Reinert, et al.. (2004). Le rachitisme symptomatique de l’adolescent. Archives de Pédiatrie. 11(7). 871–878. 20 indexed citations
6.
Béghin, Laurent, Frédèric Gottrand, L. Michaud, et al.. (2003). Impact of Intravenous Antibiotic Therapy on Total Daily Energy Expenditure and Physical Activity in Cystic Fibrosis Children with Pseudomonas aeruginosa Pulmonary Exacerbation. Pediatric Research. 54(5). 756–761. 13 indexed citations
7.
Pouessel, Guillaume, C. Thumerelle, Véronique Nève, et al.. (2003). [Reproducibility of the shuttle walk test in children with cystic fibrosis].. PubMed. 20(5 Pt 1). 711–8. 12 indexed citations
8.
Vic, P., S. Ategbo, Dominique Turck, et al.. (1998). Efficacy, tolerance, and pharmacokinetics of once daily tobramycin for pseudomonas exacerbations in cystic fibrosis. Archives of Disease in Childhood. 78(6). 536–539. 78 indexed citations
9.
Vic, P., S. Ategbo, Frédèric Gottrand, et al.. (1997). Nutritional impact of antipseudomonas intravenous antibiotic courses in cystic fibrosis. Archives of Disease in Childhood. 76(5). 437–440. 24 indexed citations
10.
Thevenot, Paul, Frédèric Gottrand, Guy‐André Loeuille, et al.. (1996). Transplantation hépatique chez une adolescente atteinte de mucoviscidose. Archives de Pédiatrie. 3(12). 1248–1252. 1 indexed citations
11.
Vic, P., S. Ategbo, Dominique Turck, et al.. (1996). Tolerance, pharmacokinetics and efficacy of once daily amikacin for treatment of Pseudomonas aeruginosa pulmonary exacerbations in cystic fibrosis patients. European Journal of Pediatrics. 155(11). 948–953. 32 indexed citations
12.
Loeuille, Guy‐André, M David, & Maguelone G. Forest. (1990). Prenatal treatment of congenital adrenal hyperplasia: Report of a new case. European Journal of Pediatrics. 149(4). 237–240. 10 indexed citations
13.
Moreno, L., et al.. (1989). [Growth and bone maturity during congenital hypothyroidism screened in the neonatal period. Apropos of 82 cases].. PubMed. 46(10). 723–8. 3 indexed citations
14.
Loeuille, Guy‐André, et al.. (1988). [Phyllodes tumor of the breast in an 11-year-old child].. PubMed. 43(5). 405–8. 2 indexed citations
15.
Loeuille, Guy‐André, et al.. (1983). [A critical study of Technetium 99m and Xenon 133 lung scintigraphy in patients with cystic fibrosis].. PubMed. 30(2). 2043–8. 2 indexed citations
16.
Loeuille, Guy‐André, A Racadot, P. Vasseur, & B. Vandewalle. (1981). [Blood and urinary aldosterone levels in normal neonates, infants and children].. PubMed. 36(5). 335–44. 3 indexed citations
17.
Farriaux, J. P., et al.. (1980). Congenital Thyroid Binding Globulin (TBG) deficiency. Its incidence on a screening program for neonatal hypothyroidism: 92. Pediatric Research. 14(2). 179–180. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026